Determination of polymicrobial burden in two postmortem brain regions in AD patients and controls with varying levels of AD-related pathology and cognitive status

This research focuses on determining the polymicrobial burden in two postmortem brain regions in individuals with Alzheimer’s disease (AD) and in control subjects, spanning a range of AD-related neuropathology and cognitive status. The project seeks to characterize and compare the presence, distribution, and relative burden of multiple microbial species in defined brain regions, using postmortem tissue from donors with varying degrees of Alzheimer’s pathology as well as cognitively diverse control cases. By applying a comparative framework across two anatomically distinct brain regions, the study aims to identify patterns that may associate polymicrobial presence with neuropathological staging, symptomatology, or resilience factors. The work recognizes Alzheimer’s disease as a complex, heterogeneous condition in which non-neuronal factors—including possible microbial contributions—warrant systematic investigation. Through controlled comparisons between AD-affected and control brains, and by stratifying cases according to documented AD-related pathology and cognitive status, the project intends to produce data that clarify whether polymicrobial signatures differ by disease status or correlate with established markers of AD pathology.

Because the project centers on postmortem analysis, it enables direct examination of brain tissue from donors representing a range of clinical and pathological presentations. Focusing on two brain regions allows the research to evaluate region-specific differences in microbial burden that may reflect differential vulnerability, exposure, or tissue environment. The comparative design between AD and control cases, and across levels of pathology and cognition, is intended to improve understanding of associations between microbial burden and the neuropathological hallmarks of AD. Findings generated by this study may help contextualize whether observed microbial patterns are widespread or regionally concentrated and whether they track with disease progression or cognitive decline.

The study’s outcomes will inform subsequent research directions by providing foundational data on polymicrobial distributions in human brain tissue in relation to Alzheimer’s pathology. Results could suggest hypotheses about potential mechanisms by which microbes might interact with neurodegenerative processes, or alternatively support interpretations that polymicrobial presence is unrelated to disease status. By documenting microbial burden systematically and in relation to well-characterized pathological and cognitive phenotypes, the project seeks to add rigorously collected evidence to the broader conversation about microbe–brain relationships in aging and neurodegeneration. This investigation contributes to institutional research efforts examining biological contributors to brain health and disease, and offers a clear, focused approach to assessing polymicrobial burden across clinically and pathologically diverse human samples. The data, interpretations and questions generated by this work will be relevant to neuropathologists, neuroscientists, infectious disease researchers and clinicians interested in the multifactorial determinants of Alzheimer’s disease outcomes.